Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

IP.BK

Strong BuyFull House

Inter Pharma Public Company Limited · Healthcare · Thailand · $90M · Avg Vol: $53K/d

93
StockRank
Get insider-trade alerts
Q
64
V
61
M
70
P/E (TTM)
21.2x
ROE
6.8%
D/E
0.2x
Dividend %
1.5%

COMPANY DESCRIPTION

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics.

FINANCIAL SUMMARY (THB)

Year2022202320242025CAGRTTM
Revenue1.5B1.8B1.9B2.2B12.9%2.3B
EPS (THB)0.220.080.060.20-3.3%0.23
Shares605.3M605.3M605.3M605.3M-0.0%605.3M
Debt539.0M399.7M394.4M400.9M-9.4%363.3M
Equity1.9B1.9B1.9B2.1B2.2%
Op CF143.1M121.4M177.8M307.9M29.1%239.9M
Inv CF-588.1M-232.8M-310.0M-170.5M
Fin CF1.0B-252.9M-95.4M-41.3M
Loading 1Y...
PRICE (1Y)-8.8%
0.150.150.160.160.17Jul 30Aug 20Sep 9
SMA 50SMA 200

Close
$0.1485
RSI (14)
32.0
52W High
$0.1719
From 52W High
0.9%

SCORE BREAKDOWN

Quality
64
ROIC
8.3%65.6
ROE
6.8%60.7
GP/Assets
29.9%63.3
Op. Margin
9.4%61.4
FCF/Assets
3.7%64.1
Piotroski
894.2
Int. Cover
12.6x65.5
D/E Ratio
0.16x54.7
Current Ratio
1.79x34.3
Value
61
P/E (TTM)
21.2x57.6
EV/EBITDA
11.7x61.3
P/FCF
24.5x55.1
P/B
1.4x75.4
P/S
1.3x78.9
Div Yield
1.5%41.8
Momentum
70
52W High %
86%77.6
RS 6M
-2%62.5
SMA 50/200
1.16x84.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
19%54.6

FUNDAMENTALS

Market Cap
$90M
P/E (Forward)
Gross Margin
42.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IP.BK are excluded.

TickerCompanyMkt CapStockRankSignal
IP.BKInter Pharma Public Company Limited(you)$90M93Strong Buy
NTV.BKNonthavej Hospital Public Company Limited$93M89Strong Buy
TOG.BKThai Optical Group Public Company Limited$102M90Strong Buy
RPH.BKRatchaphruek Hospital Public Company Limited$79M89Strong Buy
RJH.BKRajthanee Hospital Public Company Limited$135M95Strong Buy
BIZ.BKBusiness Alignment Public Company Limited$111M100Strong Buy
EKH.BKEkachai Medical Care Public Company Limited$127M88Strong Buy
VIH.BKSrivichaivejvivat Public Company Limited$160M98Strong Buy
TNH.BKThai Nakarin Hospital Public Company Limited$156M79Buy
SKR.BKSikarin Public Company Limited$483M92Strong Buy

Peer medians: ROE 12.2% · P/E 14.6x · Gross margin 27.9%

Inter Pharma Public Company Limited (IP.BK): Stock Score Summary

Inter Pharma Public Company Limited (IP.BK) has a MoatMap StockRank of 93/100 based on Quality (64/100), Value (61/100), and Momentum (70/100) factor scores. The current signal is STRONG BUY.

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics.

Key Financial Metrics

Price$0.15
Market Cap$90M
P/E (TTM)21.22
Price/Book1.42
Return on Equity6.8%
Return on Invested Capital8.3%
Debt/Equity0.16x
Gross Margin42.9%
Operating Margin9.4%
Revenue Growth3.1%
Dividend Yield1.5%
Free Cash Flow$4M

Inter Pharma Public Company Limited operates in the Biotechnology industry, part of the Healthcare sector (Thailand).

Frequently Asked Questions

What is Inter Pharma Public Company Limited’s (IP.BK) StockRank?
MoatMap’s StockRank for Inter Pharma Public Company Limited (IP.BK) is 93/100, with a Strong Buy signal. It is a composite of Quality (64), Value (61), and Momentum (70) factor ranks across MoatMap’s 20,000+ stock universe.
Does Inter Pharma Public Company Limited have an economic moat?
Inter Pharma Public Company Limited (IP.BK) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Inter Pharma Public Company Limited a buy, hold, or sell?
MoatMap’s current signal for Inter Pharma Public Company Limited (IP.BK) is Strong Buy, based on a StockRank of 93/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Inter Pharma Public Company Limited in?
Inter Pharma Public Company Limited (IP.BK) operates in the Healthcare sector, specifically the Biotechnology industry (Thailand).